Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page template to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:28:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a 'Show glossary' feature and updated footer/labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the revision to v3.4.0. The changes are cosmetic and do not modify the study information.
    Difference
    0.2%
    Check dated 2026-01-28T06:01:31.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:10.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Locations now appear under the study details with a Washington site listed. The page update changes the revision from v3.3.2 to v3.3.3 and removes the Washington Locations and HHS Vulnerability Disclosure items from the footer area.
    Difference
    0.2%
    Check dated 2025-12-23T09:46:59.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing the previous v3.3.1 revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:41:09.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.1 with no changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:11:34.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.